Animation & coordination

Animation and coordination of research

ANRS | Emerging Infectious Diseases is playing a key role to promote interactions between the main stakeholders involved in the response to the COVID-19 pandemic. One of its main goals is to identify gaps in research and to foster the emergence of innovative and collaborative projects. Thus, ANRS | Emerging Infectious Diseases has initiated several working groups, to animate and coordinate research on identified themes, but also to bring out projects considered to be priorities and accompany them towards an urgent implementation. It has also focused on promoting good practices and standardization of data collection in clinical research, as well as links with industrials to favor potential collaborations with researchers. 

Scientific animation and bibliographical support to the thematic working groups

Therapeutics Working Group:

Hospital

More

Therapeutics Working Group:

Outpatient Clinical Trials in population at risk

More

Therapeutics Working Group:

Chemoprophylaxis

More

Immunology and inflammation Working Group

More

Long COVID Working Group

More

Task Force "COVID-19 in Low and Middle Income Countries"

More

Transmission studies Working Group

More

Saliva Testing Studies Group

More

Human and Social Sciences Working Group on COVID-19

More

Working groups supporting clinical research

Preclinical Studies Working Group

Treatments Prioritization Working Group

Monoclonal Antibodies Therapeutics Working Group

In close collaboration with the International Severe Acute Respiratory & Emerging Infection Consortium (ISARIC), the REACTing-ANRS | EID  Methodology Centre carried out the French translation of the electronic case report form (eCRF), in order to harmonize data collection for an observational study. The recommendations made by REACTing-ANRS | EID on the types of samples to be taken, the frequency of sampling and the temperature at which the specimens should be kept are the sampling strategy used since the end of January in France.

The Health Industry Alliance for Research and Innovation (ARIIS) and REACTing - ANRS | EID have strengthened ties since the beginning of the COVID-19 pandemic. Their primary objective has been to facilitate and stimulate discussions between public, private and governmental sectors in order to favour the development of novel initiatives and potential public-private partnerships (PPP) to accelerate research against COVID-19. Parties involved include clinical research laboratories, patient and population cohorts, pharmaceutical industries, start-ups, and the French Ministries for Health, Research and Innovation.


The main missions of this initiative are to:

  • Promote interactions and coordination between the public and private research sectors.
  • Propose improved standardised operating procedures and prioritisation processes to facilitate access of private institutions to biological clinical samples and national biobanks for use in novel diagnostic, therapeutic or vaccine evaluation or screening tests.
  • Facilitate discussions between private sector institutions and public clinical research institutions for the establishment of potential public-private partnerships (PPP) in close collaboration with Inserm-Transfert.